Peptide Safety for Women
Women's peptide research carries specific safety considerations related to hormonal balance, reproductive health, and metabolic differences from male biology.
Hormonal Considerations
The Venus Protocol specifically avoids androgens (testosterone, anavar) and anabolic steroids that can cause virilization in women (facial hair, voice deepening, acne, clitoral enlargement). All 10 compounds are peptides or coenzymes that work with female hormonal physiology rather than overriding it.
Fertility & Pregnancy
No research peptides should be used during pregnancy, while attempting to conceive, or during breastfeeding. GLP-1 agonists (retatrutide, semaglutide) may require a washout period before conception attempts. All products are for laboratory research only.
Compound Interactions
- Retatrutide and GLP-1 agonists delay gastric emptying — may affect absorption of oral medications
- NAD+ and glutathione are complementary antioxidants at standard research doses
- CJC-1295 + Ipamorelin are specifically designed to be combined (synergistic GH release)
- BPC-157 NO modulation may affect blood pressure compounds
Sourcing Safety
Only source from verified vendors with third-party COAs. QSC Peptides publishes Janoshik-verified COAs on every product page.
All products are for laboratory research only. Medical experts recommend professional supervision.
The Venus Protocol — 10 Compounds
All 10 compounds from QSC. ≥99% HPLC purity, Janoshik COA, free domestic shipping from USA, EU, UK, CA, AU.
Shop the Venus Protocol at QSC →Venus Protocol
Buy Compounds